BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20110451)

  • 1. Endoprotease profiling with double-tagged peptide substrates: a new diagnostic approach in oncology.
    Peccerella T; Lukan N; Hofheinz R; Schadendorf D; Kostrezewa M; Neumaier M; Findeisen P
    Clin Chem; 2010 Feb; 56(2):272-80. PubMed ID: 20110451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability.
    Findeisen P; Costina V; Yepes D; Hofheinz R; Neumaier M
    J Exp Clin Cancer Res; 2012 Jun; 31(1):56. PubMed ID: 22682081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
    Yepes D; Jacob A; Dauber M; Costina V; Hofheinz R; Neumaier M; Findeisen P
    Int J Oncol; 2011 Jul; 39(1):145-54. PubMed ID: 21503574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool.
    Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex profiling of tumor-associated proteolytic activity in serum of colorectal cancer patients.
    Yepes D; Costina V; Pilz LR; Hofheinz R; Neumaier M; Findeisen P
    Proteomics Clin Appl; 2014 Jun; 8(5-6):308-16. PubMed ID: 24616428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional protease profiling for diagnosis of malignant disease.
    Findeisen P; Neumaier M
    Proteomics Clin Appl; 2012 Jan; 6(1-2):60-78. PubMed ID: 22213637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional protease profiling for laboratory based diagnosis of invasive aspergillosis.
    Sabbagh B; Costina V; Buchheidt D; Reinwald M; Neumaier M; Findeisen P
    Int J Oncol; 2015 Jul; 47(1):143-50. PubMed ID: 25954923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
    Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
    Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
    Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers.
    Karczmarski J; Rubel T; Mikula M; Wolski J; Rutkowski A; Zagorowicz E; Dadlez M; Ostrowski J
    Acta Biochim Pol; 2013; 60(3):417-25. PubMed ID: 24046818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression.
    Bedin C; Crotti S; Ragazzi E; Pucciarelli S; Agatea L; Tasciotti E; Ferrari M; Traldi P; Rizzolio F; Giordano A; Nitti D; Agostini M
    J Cell Physiol; 2016 Apr; 231(4):915-25. PubMed ID: 26379225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved reporter ion assignment of raw isobaric stable isotope labeled liquid chromatography/matrix-assisted laser desorption/ionization tandem time-of-flight mass spectral data for quantitative proteomics.
    Jakoby T; Tholey A; van den Berg BH
    Rapid Commun Mass Spectrom; 2012 Dec; 26(23):2777-85. PubMed ID: 23124669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescein as a versatile tag for enhanced selectivity in analyzing cysteine-containing proteins/peptides using mass spectrometry.
    Chen SH; Hsu JL; Lin FS
    Anal Chem; 2008 Jul; 80(13):5251-9. PubMed ID: 18512949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.
    Koomen JM; Zhao H; Li D; Nasser W; Hawke DH; Abbruzzese JL; Baggerly KA; Kobayashi R
    Rapid Commun Mass Spectrom; 2005; 19(12):1624-36. PubMed ID: 15915451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FPPS: Fast Profiling of Protease Specificity.
    Vizovišek M; Vidmar R; Fonović M
    Methods Mol Biol; 2017; 1574():183-195. PubMed ID: 28315251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of low-abundance cancer biomarker candidate TIMP1 from serum with lectin fractionation and peptide affinity enrichment by ultrahigh-resolution mass spectrometry.
    Ahn YH; Kim KH; Shin PM; Ji ES; Kim H; Yoo JS
    Anal Chem; 2012 Feb; 84(3):1425-31. PubMed ID: 22196688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
    Huijbers A; Mesker WE; Mertens BJ; Bladergroen MR; Deelder AM; van der Burgt YE; Tollenaar RA
    Colorectal Dis; 2014 Nov; 16(11):907-13. PubMed ID: 25243779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.